ARCHIVES

Politics May Play Role In FDA’s Avastin Decision

This article is from The Cancer Letter archive.

Vol. 37 No. 21 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: NCAB Lacked Courage On Some Special Actions, Amos Says; Pick Reviewers On Ability Only, Scientist Asks

July 30, 1982

Wyngaarden Opens Up Search for NCI Director, Invites Recommendations From Cancer Groups

September 30, 1988

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006

NSABP Roundup: Fisher, Pitt Negotiating; 9th Chairman Candidate

October 7, 1994

QOL Of Young Survivors Equal To Other Children

February 25, 2005